PIR and metastatic neoplasm: piR-57,125, piR-30,924, and piR-38,756 are potential prognostic biomarkers of ccRCC because the high expression of piR-30,924 and piR-38,756 and low expression of piR-57,125 significantly correlates with the metastatic tumors and bone metastasis.